Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  heterogeneity 




 
Kaplan Qbank USMLE



Author7 Posts
  #1

can someone please explain the difference between

Genetic heterogeneity
Locus heterogeneity
allelic heterogeneity
variable Expressivity
incomplete penetrance.
thanks

  #2

1. A 24-year-old woman with myotonic dystrophy has significant muscle weakness and wasting. She has a one-year-old son with very poor muscle tone and severe weakness and significant development delay. Her affected 55-year-old father has cataracts but no muscle weakness.D. Anticipation


2. A man and woman, each of whom has autosomal recessive congenital deafness, have four biological children, each of whom has normal hearing. Locus heterogeneity


3. A 40-year-old man with neurofibromatosis (NF1) has a plexiform neurofibroma of his leg that has caused significant disfigurement, and hundreds of cutaneous neurofibromas. His 43-year-old sister has cafe-au-lait spots and Lisch nodules of the iris, but no neurofibromas. His 19-year-old son has cafe-au-lait spots, a dozen cutaneous neurofibromas, and scoliosis (curvature of the spine).Variable expressivity


Edited by msyamp on 02/05/06 - 04:30 PM

___________________
If you think you can You can! If you think you cant you are right again!!

  #3

About 10% of pheochromocytomas (a tumor of the adrenal medulla) occur in patients with familial cancer syndromes, one of which is multiple endocrine neoplasia syndrome, type II (MEN-II). In most MEN-II families, there are germline mutations in the RET gene, located on chromosome 10. Most commonly, these mutations are in one of several different codons encoding cysteines. This is an example of:Allelic heterogeneity



. MEN-II is an autosomal dominant cancer syndrome. Another autosomal dominant cancer syndrome associated with pheochromocytomas (and occasionally misdiagnosed as MEN-II) is von Hippel-Lindau disease, the gene for which is on chromosome 3. With regard to familial pheochromocytomas, these two diseases are examples of Locus heterogeneity

95% of individuals affected with MEN-II have thyroid C-cell hyperplasia and medullary thyroid carcinoma, 50% have pheochromocytoma, and about 20% have hyperparathyroidism. This is an example of:Variable expressivity





___________________
If you think you can You can! If you think you cant you are right again!!

  #4

Retinoblastoma has a penetrance of about 75% (incomplete penetrance) - only about 3/4 of the individuals with the genotype for retinoblastoma susceptibility actually get the disease. On the other hand, the dominantly inherited neurodegenerative disease Huntington's disease has a penetrance of 100% (complete penetrance) - everyone with at least one copy of the Huntington's allele will get the disease

___________________
If you think you can You can! If you think you cant you are right again!!

  #5

great msyamp ,thanks.
what about genetic heterogeneity?



  #6

genetic heterogenety is of two types.

1. allelic

2. locus


___________________
If you think you can You can! If you think you cant you are right again!!

  #7

oh ok,so it's the big term.thanks msyamp...








You don't have permission to post.




Login or Register to post messages in this topic





















Contact | Leaders | Disclaimer | Privacy

Copyright @ Prep for USMLE. All rights reserved.